The STABLE system performs Computerized Dynamic Posturography (CDP) assessments of balance health using a compact multi-axis motion platform and virtual reality headset. Work concluded on the clinical evaluation and the system was shown to be statistically equivalent to a criterion system. A follow-on Phase II contract was awarded to add functionality, optimize for manufacturing, construct […]
News
Barron Associates’ Pain Assessment Technology Completes Phase II SBIR Clinical Study
Chronic pain is an internal experience that cannot be directly observed or measured. Pain assessment, therefore, is exceptionally challenging, relying largely on self-report measures. The objective of this study is to develop and demonstrate the KnowPain system, an innovative wrist-worn instrument for objectively assessing the functional impact of pain (FIP) throughout the course of a […]
Barron Associates’ Continuous, Non-invasive Blood Pressure Monitor Completes Validation Study
High blood pressure is a substantial public health problem that affects 45% of adults (75% of individuals over age 65) and is a leading cause of excess cardiovascular morbidity and mortality. Static BP snapshots, which are typically obtained via sphygmomanometry during doctor’s office visits, have documented reliability issues, including white coat hypertension and poor technique. […]
Full patent granted for automated olfactory training system
The second full patent for Barron’s automated olfactory stimulus and training system (12337082) was granted, focusing on system and device aspects. This system was developed under numerous contracts seeking to automate the process of training rats to detect explosive odors.
Barron Associates’ Hospital Fall Detection System Successfully Completes Hospital Field Trial
Falls represent a significant healthcare problem with substantial associated morbidity and mortality. In an inpatient environment, it is necessary to identify injurious falls quickly to reduce the potential for serious or fatal injuries. Falls are consistently the most frequently reported adverse event in hospitals; up to 20% of patients fall at least once during their […]
Barron Associates’ Awarded Canadian Patent for Fall Detection Methodology
Barron Associates’ fall detection technology, which was previously patented in the United States, received approval for Canadian Patent Application No. 3,074,729.
Barron Associates’ Continuous, Non-invasive Blood Pressure Monitor Begins Human Subjects Study
High blood pressure is a substantial public health problem that affects 45% of adults (75% of individuals over age 65) and is a leading cause of excess cardiovascular morbidity and mortality. Static BP snapshots, which are typically obtained via sphygmomanometry during doctor’s office visits, have documented reliability issues, including white coat hypertension and poor technique. […]
Barron Associates’ Hospital Fall Detection System Begins Hospital Field Trial
Falls represent a significant healthcare problem with substantial associated morbidity and mortality. In an inpatient environment, it is necessary to identify injurious falls quickly to reduce the potential for serious or fatal injuries. Falls are consistently the most frequently reported adverse event in hospitals; up to 20% of patients fall at least once during their […]
Army Selects Barron Associates to Develop Machine Translation Capabilities for Low-Resource Languages
Barron Associates has been selected for a Phase II SBIR award to develop and demonstrate a comprehensive set of tools to support efficient deployment of assured MT systems for low-resource languages, including deployment of new systems for languages not previously supported, and performance optimization for specific domains and/or for specific downstream tasks. The ACE-Translation design […]
Barron Associates Receives Phase II SBIR Grant to Develop Device for Freezing of Gait in Patients with Parkinson’s Disease
Parkinson’s Disease (PD) is a common neurodegenerative disorder that affects 1 million Americans and 10 million individuals worldwide. One of the most debilitating and impactful symptoms of PD is Freezing of Gait (FOG). FOG is a “mysterious phenomenon” with a pathophysiology that is not fully understood. FOG decreases quality of life and activity level, and […]
